![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF "Quad" Compared to Ritonavir-boosted Atazanavir plus Emtricitabine/Tenofovir DF in Treatment Na•ve HIV-1 Infected Subjects
|
|
|
Reported by Jules Levin
19th CROI, Seattle March 8, 2012
E DeJesus1, JK Rockstroh2, K Henry3, J-M Molina4, J Gathe5, S Ramanathan6, X Wei6, J Szwarcberg6, M Rhee6, and A Cheng6
1Orlando Immunology Center, Orlando, FL, US; 2Department of Medicine I, University of Bonn, Bonn, Germany; 3Hennepin County Medical Center, Minneapolis, MN, US; 4Saint Louis Hospital, Paris, France; 5Therapeutic Concepts P.A., Houston, TX, US; 6Gilead Sciences, Inc., Foster City, CA, US
![CROI1.gif](../images/030912/030912-1/CROI1.gif)
![CROI2.gif](../images/030912/030912-1/CROI2.gif)
![CROI3.gif](../images/030912/030912-1/CROI3.gif)
![CROI4.gif](../images/030912/030912-1/CROI4.gif)
![CROI5.gif](../images/030912/030912-1/CROI5.gif)
![CROI6.gif](../images/030912/030912-1/CROI6.gif)
![CROI7.gif](../images/030912/030912-1/CROI7.gif)
![CROI8.gif](../images/030912/030912-1/CROI8.gif)
![CROI9.gif](../images/030912/030912-1/CROI9.gif)
![CROI10.gif](../images/030912/030912-1/CROI10.gif)
![CROI11.gif](../images/030912/030912-1/CROI11.gif)
![CROI12.gif](../images/030912/030912-1/CROI12.gif)
![CROI13.gif](../images/030912/030912-1/CROI13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|